La presente informativa è resa, anche ai sensi dell’art. 13 del D. Lgs. 196/2003 “Codice in materia di protezione dei dati personali” (“Codice Privacy”) 
e degli artt. 13 e 14 del Regolamento (UE) 2016/679 (“GDPR”), a coloro che si collegano alla presente edizione online del giornale Tribuna Economica di proprietà di AFC Editore Soc. Coop. 

Leggi di più

I TWEET

@bancaditalia . L'economia globale recupera ma le prospettive dipendono dalla #pandemia . In Italia riprendono gli… https://t.co/1kVsYKGZsL
Rebibbia Festival e streaming dal Gemelli. Due appuntamenti ricorrenti della @romacinemafest https://t.co/NFTBj4hUaq via @TribunaEconomic
#Bankitalia. L'economia globale recupera ma le prospettive dipendono dalla #pandemia . In #Italia riprendono gli s… https://t.co/oxwmmV4AR0

The Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Veklury, the brand name for Remdesivir, and the opportunity to increase supply beyond the 500,000 treatment courses.

There are  36 signatories of the Joint Procurement Agreementparticipating in this joint procurement, including all EU countries, the EEA countries of Norway and Iceland, the UK, as well as six candidate countries and potential candidates (Albania, the Republic of North Macedonia, Montenegro, Serbia, Kosovo** and Bosnia and Herzegovina). All participating countries can now place their orders to procure Veklury directly. Veklury is at this stage the only medicine with a conditional marketing authorisation in the EU for the treatment of COVID-19 patients needing oxygen supply.

The signature of this joint procurement framework contract follows the Commission's contract with Gilead to secure 33,380 treatment courses of Veklury that have been distributed across the EU and the UK since August. This contract was financed from the Commission's Emergency Support Instrument (ESI), worth a total of EUR 70 million.

The treatment courses purchased with ESI funding have helped to cover the immediate needs from August until October to ensure that critical patients receive the treatments. The medication has been disbursed in several instalments. The joint procurement contract will now ensure that countries will continue to have an uninterrupted supply of Veklury if they decide to procure the product.